Research Alliance Corp. II Class A Common Stock
RACB
RACB was delisted on the 1st of December, 2022.
40 hedge funds and large institutions have $137M invested in Research Alliance Corp. II Class A Common Stock in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 5 closing their positions.
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
3% more funds holding
Funds holding: 39 → 40 (+1)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
1% less capital invested
Capital invested by funds: $139M → $137M (-$1.85M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$5.61M |
| 2 |
Jane Street
New York
|
+$4.69M |
| 3 |
JP Morgan Chase
New York
|
+$3.43M |
| 4 |
Goldman Sachs
New York
|
+$3.19M |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$2.69M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$9.8M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$8.07M |
| 3 |
SCM
Suvretta Capital Management
New York
|
-$4.9M |
| 4 |
CL
CSS LLC
Chicago,
Illinois
|
-$1.91M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.89M |
RACB Hedge Fund Activity: Q3 2022 in Review
40 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Research Alliance Corp. II Class A Common Stock (RACB) for Q3 2022, worth a combined $137M — down 1.3% from $139M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new RACB positions and 5 closed out — a net gain of 1 holder — while 8 added to existing stakes and 8 trimmed.
The largest buyer was First Trust Capital Management, adding an estimated $5.61M. The largest seller was Bain Capital Life Sciences Investors, exiting entirely with an estimated $9.8M sold.
- 40 institutional investors held Research Alliance Corp. II Class A Common Stock (RACB) as of Q3 2022, up from 39 in Q2 2022.
- Funds reported $137M of Research Alliance Corp. II Class A Common Stock stock for Q3 2022, down 1.3% quarter-over-quarter.
- 6 funds opened new Research Alliance Corp. II Class A Common Stock positions in Q3 2022 and 5 closed out, a net change of +1 holder.
- The largest Research Alliance Corp. II Class A Common Stock buyer in Q3 2022 was First Trust Capital Management, an estimated $5.61M added.
- The largest Research Alliance Corp. II Class A Common Stock seller in Q3 2022 was Bain Capital Life Sciences Investors, an estimated $9.8M sold.
Based on aggregated 13F filings for Q3 2022.